Transgenomic, Inc. (NASDAQ:TBIO), today announced that the company will hold its Third Quarter 2015 Financial Results and Business Update Conference Call on Thursday, November 12, 2015 at 5:00 PM ET. The company will present an overview of financial results for the third quarter in a press release issued after the market close that day.
To participate in the call, dial 866-952-8561 from the U.S. and Canada or 785-424-1883 from international locations and enter conference ID: TRANS. The call will be webcast live and can be accessed at https://www.webcaster4.com/Webcast/Page/1139/11743, which is also available at the Investor Relations (IR) section of Transgenomic’s website.
A replay will be available for two weeks beginning approximately two hours after the call’s conclusion, until 11:59 PM ET November 26, 2015. To access the replay, dial 800-839-3616 (domestic) or 402-220-2974 (international). The conference call will also be archived at the IR section of the company’s website.
About Transgenomic, Inc.
Transgenomic,
Inc. is a global biotechnology company advancing personalized
medicine in cardiology, oncology, and inherited diseases through
advanced diagnostic technologies, such as its revolutionary ICE
COLD-PCR™ and its unique genetic tests provided through its Patient
Testing business. Transgenomic also provides specialized clinical and
research services to biopharmaceutical companies developing targeted
therapies and sells equipment, reagents and other consumables for
applications in molecular testing and cytogenetics. Transgenomic’s
diagnostic technologies are designed to improve medical diagnoses and
patient outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151111006474/en/